Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ross A. Soo's publication output changed over time?
ScholarIQpublication output · 2012–2020
Output grew0% over the shown period — from 2 works in 2012 to 2 in 2020.
2
2
1
3
2
2
201220132017201820192020
What are the most-cited papers on Ross A. Soo?
ScholarIQmost cited works
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Benjamin Solomon, Benjamin Besse, Todd M. Bauer, Enriqueta Felip, Ross A. Soo, D. Ross Camidge, Rita Chiari, Alessandra Bearz, Chia‐Chi Lin, Shirish M. Gadgeel, Gregory J. Riely, Eng Huat Tan, Takashi Seto, Leonard P. James, Jill S. Clancy, Antonello Abbattista, Jean-François Martini, Joseph Chen, Gerson Peltz, Holger Thurm, Sai‐Hong Ignatius Ou, Alice T. Shaw
The Lancet Oncology. 2018794 Citations
De-novo and acquired resistance to immune checkpoint targeting
Nicholas Syn, Michele W.L. Teng, Tony Mok, Ross A. Soo
The Lancet Oncology. 2017734 Citations
Isolation and retrieval of circulating tumor cells using centrifugal forces
Han Wei Hou, Majid Ebrahimi Warkiani, Bee Luan Khoo, Zirui Li, Ross A. Soo, Daniel Shao-Weng Tan, Wan‐Teck Lim, Jongyoon Han, Ali Asgar S. Bhagat, Chwee Teck Lim
Scientific Reports. 2013731 CitationsOPEN ACCESS
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Wen Cai Zhang, Ng Shyh‐Chang, Yang He, Amit Rai, Shivshankar Umashankar, Siming Ma, Boon-Seng Soh, Li Sun, Bee Choo Tai, Min En Nga, Kishore Bhakoo, Senthil Raja Jayapal, Massimo Nichane, Qiang Yu, Dokeu A. Ahmed, Christie Tan, Wong Poo Sing, John Kit Chung Tam, Thirugananam Agasthian, Monireh Soroush Noghabi, Yin Huei Pang, Haw Siang Ang, Wayne Mitchell, Paul Robson, Philipp Kaldis, Ross A. Soo, Sanjay Swarup, Elaine Hsuen Lim, Bing Lim
S110447773. 2012677 CitationsOPEN ACCESS
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Robert M. Jotte, Federico Cappuzzo, Ihor Vynnychenko, Daniil Stroyakovskiy, Delvys Rodríguez‐Abreu, Maen Hussein, Ross A. Soo, Henry Jacob Conter, Toshiyuki Kozuki, Kuan-Chieh Huang, Vilma Graupner, Shawn W. Sun, Tien Hoang, Helen Jessop, Mark L. McCleland, Marcus Ballinger, Alan Sandler, Mark A. Socinski
Journal of Thoracic Oncology. 2020614 CitationsOPEN ACCESS
Related on ScholarIQ
National University Cancer Institute, Singapore
Institution
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
Paper
De-novo and acquired resistance to immune checkpoint targeting
Paper
Isolation and retrieval of circulating tumor cells using centrifugal forces
Paper
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Paper
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Paper